[1]
Ahern E,Smyth MJ,Dougall WC,Teng MWL, Roles of the RANKL-RANK axis in antitumour immunity - implications for therapy. Nature reviews. Clinical oncology. 2018 Sep 19 [PubMed PMID: 30232468]
[2]
Jamshidi K,Gharehdaghi M,Hajialiloo SS,Mirkazemi M,Ghaffarzadehgan K,Izanloo A, Denosumab in Patients with Giant Cell Tumor and Its Recurrence: A Systematic Review. The archives of bone and joint surgery. 2018 Jul [PubMed PMID: 30175172]
[3]
Tsourdi E,Makras P,Rachner TD,Polyzos S,Rauner M,Mandanas S,Hofbauer LC,Anastasilakis AD, Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment. Bone. 2018 Oct 4 [PubMed PMID: 30292818]
[4]
Iwamoto N,Okamoto M,Tsuji S,Endo Y,Takatani A,Shimizu T,Umeda M,Fukui S,Sumiyoshi R,Igawa T,Koga T,Kawashiri SY,Aramaki T,Ichinose K,Tamai M,Nakamura H,Origuchi T,Eguchi K,Ueki Y,Kawakami A, Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs. Journal of bone and mineral metabolism. 2018 Sep 5 [PubMed PMID: 30187273]
[5]
Briot K,Paccou J,Beuzeboc P,Bonneterre J,Bouvard B,Confavreux CB,Cormier C,Cortet B,Hannoun-Lévi JM,Hennequin C,Javier RM,Lespessailles E,Mayeur D,Artus PM,Vieillard MH,Debiais F, French Recommendations for Osteoporosis Prevention and Treatment in Patients with Prostate Cancer Treated by Androgen Deprivation. Joint, bone, spine : revue du rhumatisme. 2018 Oct 1 [PubMed PMID: 30287350]
[6]
Otto S,Pautke C,Van den Wyngaert T,Niepel D,Schiødt M, Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer treatment reviews. 2018 Sep [PubMed PMID: 30055439]
[7]
Chung TL,Chen NC,Chen CL, Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2018 Aug 31 [PubMed PMID: 30171299]
[8]
Saleem S,Patel S,Ahmed A,Saleem N, Denosumab causing severe, refractory hypocalcaemia in a patient with chronic kidney disease. BMJ case reports. 2018 May 30 [PubMed PMID: 29848528]
[9]
Starr J,Tay YKD,Shane E, Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures. Current osteoporosis reports. 2018 Aug [PubMed PMID: 29951870]
[10]
Imatoh T,Sai K,Takeyama M,Hori K,Karayama M,Furuhashi K,Segawa K,Kimura M,Kawakami J,Saito Y, Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemia. Journal of clinical pharmacy and therapeutics. 2018 Aug 24 [PubMed PMID: 30144112]